XNAS · Healthcare · Medical Instruments & Supplies
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
NexGel’s quarter was weak: revenue only **$4M** missed estimates and EPS worsened to **-$0.40** from **-$0.09** last year. With no meaningful catalyst and a **-26.3%** margin, the medical supplies microcap looks stalled despite top-line growth off a tiny base.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | Q2 2026 | -0.12 | -0.40 | -233.33% | $3.7M | ❌ Miss | -1.91% | +1.20% | — |
| 2026-05-14 | Q1 2026 | -0.07 | -0.11 | -57.14% | $2.6M | ❌ Miss | +1.48% | -1.29% | +1.66% |
| 2026-03-31 |
| Q4 2025 |
| -0.09 |
| -0.12 |
| -33.33% |
| $2.8M |
| ❌ Miss |
| +4.27% |
| -3.48% |
| -6.76% |
| 2025-11-11 | Q3 2025 | -0.08 | -0.08 | +0.00% | $2.9M | ➖ Inline | — | — | — |
| 2025-08-12 | Q2 2025 | -0.07 | -0.09 | -28.57% | $2.9M | ❌ Miss | -3.69% | -11.81% | -8.86% |
| 2025-03-24 | Q4 2024 | -0.13 | -0.11 | +15.38% | $3.0M | ✅ Beat | -1.94% | -3.56% | -12.62% |
| 2024-11-13 | Q3 2024 | -0.10 | -0.11 | -10.00% | $2.9M | ❌ Miss | -3.34% | +0.30% | +43.16% |
| 2024-08-14 | Q2 2024 | -0.14 | -0.14 | +0.00% | $1.4M | ➖ Inline | -5.61% | -7.37% | -4.56% |
Showing last 8 quarters.